• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铁在氧自由基介导的脂质过氧化中的作用。

The role of iron in oxygen radical mediated lipid peroxidation.

作者信息

Minotti G, Aust S D

机构信息

Institute of General Pathology, Catholic University, Rome, Italy.

出版信息

Chem Biol Interact. 1989;71(1):1-19. doi: 10.1016/0009-2797(89)90087-2.

DOI:10.1016/0009-2797(89)90087-2
PMID:2550151
Abstract

The role of iron in the peroxidation of polyunsaturated fatty acids is reviewed, especially with respect to the involvement of oxygen radicals. The hydroxyl radical can be generated by a superoxide-driven Haber-Weiss reaction or by Fenton's reaction; and the hydroxyl radical can initiate lipid peroxidation. However, lipid peroxidation is frequently insensitive to hydroxyl radical scavengers or superoxide dismutase. We propose that the hydroxyl radical may not be involved in the peroxidation of membrane lipids, but instead lipid peroxidation requires both Fe2+ and Fe3+. The inability of superoxide dismutase to affect lipid peroxidation can be explained by the fact that the direct reduction of iron can occur, exemplified by rat liver microsomal NADPH-dependent lipid peroxidation. Catalase can be stimulatory, inhibitory or without affect because H2O2 may oxidize some Fe2+ to form the required Fe3+, or, alternatively, excess H2O2 may inhibit by excessive oxidation of the Fe2+. In an analogous manner reductants can form the initiating complex by reduction of Fe3+, but complete reduction would inhibit lipid peroxidation. All of these redox reactions would be influenced by iron chelation.

摘要

本文综述了铁在多不饱和脂肪酸过氧化反应中的作用,尤其涉及氧自由基的参与情况。羟基自由基可通过超氧化物驱动的哈伯-维伊斯反应或芬顿反应产生;且羟基自由基可引发脂质过氧化。然而,脂质过氧化通常对羟基自由基清除剂或超氧化物歧化酶不敏感。我们提出羟基自由基可能不参与膜脂质的过氧化反应,相反,脂质过氧化需要Fe2+和Fe3+两者。超氧化物歧化酶无法影响脂质过氧化这一现象可通过铁能直接被还原这一事实来解释,以大鼠肝微粒体中依赖NADPH的脂质过氧化为例。过氧化氢酶可能具有促进、抑制或无影响的作用,因为过氧化氢可能将一些Fe2+氧化以形成所需的Fe3+,或者,过量的过氧化氢可能因Fe2+的过度氧化而产生抑制作用。以类似的方式,还原剂可通过还原Fe3+形成引发复合物,但完全还原会抑制脂质过氧化。所有这些氧化还原反应都会受到铁螯合作用的影响。

相似文献

1
The role of iron in oxygen radical mediated lipid peroxidation.铁在氧自由基介导的脂质过氧化中的作用。
Chem Biol Interact. 1989;71(1):1-19. doi: 10.1016/0009-2797(89)90087-2.
2
Redox cycling of iron and lipid peroxidation.铁的氧化还原循环与脂质过氧化作用
Lipids. 1992 Mar;27(3):219-26. doi: 10.1007/BF02536182.
3
NADPH- and adriamycin-dependent microsomal release of iron and lipid peroxidation.烟酰胺腺嘌呤二核苷酸磷酸(NADPH)和阿霉素依赖的微粒体铁释放及脂质过氧化作用。
Arch Biochem Biophys. 1990 Mar;277(2):268-76. doi: 10.1016/0003-9861(90)90578-m.
4
Possible sources of iron for lipid peroxidation.脂质过氧化反应中铁的可能来源。
Free Radic Res Commun. 1991;12-13 Pt 1:99-106. doi: 10.3109/10715769109145773.
5
The requirement for iron (III) in the initiation of lipid peroxidation by iron (II) and hydrogen peroxide.铁(II)和过氧化氢引发脂质过氧化过程中对铁(III)的需求。
J Biol Chem. 1987 Jan 25;262(3):1098-104.
6
[Free oxygen radiacals and kidney diseases--part I].[游离氧自由基与肾脏疾病——第一部分]
Med Pregl. 2000 Sep-Oct;53(9-10):463-74.
7
Reactions of adriamycin with microsomal iron and lipids.阿霉素与微粒体铁和脂质的反应。
Free Radic Res Commun. 1989;7(3-6):143-8. doi: 10.3109/10715768909087936.
8
The involvement of iron in lipid peroxidation. Importance of ferric to ferrous ratios in initiation.铁在脂质过氧化中的作用。三价铁与二价铁比例在引发过程中的重要性。
J Biol Chem. 1986 Aug 5;261(22):10282-9.
9
The role of iron chelates in hydroxyl radical production by rat liver microsomes, NADPH-cytochrome P-450 reductase and xanthine oxidase.铁螯合物在大鼠肝微粒体、NADPH-细胞色素P-450还原酶和黄嘌呤氧化酶产生羟自由基过程中的作用。
Arch Biochem Biophys. 1984 Jul;232(1):378-90. doi: 10.1016/0003-9861(84)90553-8.
10
Superoxide-dependent lipid peroxidation. Problems with the use of catalase as a specific probe for fenton-derived hydroxyl radicals.超氧化物依赖性脂质过氧化。将过氧化氢酶用作铁离子诱导产生的羟基自由基特异性探针的问题。
Biochem Biophys Res Commun. 1983 Dec 28;117(3):901-7. doi: 10.1016/0006-291x(83)91681-9.

引用本文的文献

1
Ferroptosis as a potential molecular mechanism of bipolar disorder.铁死亡作为双相情感障碍的一种潜在分子机制。
Transl Psychiatry. 2025 Jun 19;15(1):205. doi: 10.1038/s41398-025-03429-w.
2
Ferroptosis in schizophrenia: Mechanisms and therapeutic potentials (Review).精神分裂症中的铁死亡:机制与治疗潜力(综述)。
Mol Med Rep. 2025 Feb;31(2). doi: 10.3892/mmr.2024.13402. Epub 2024 Nov 29.
3
Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects.铁稳态和铁死亡在人类疾病中的作用:机制和治疗前景。
Signal Transduct Target Ther. 2024 Oct 14;9(1):271. doi: 10.1038/s41392-024-01969-z.
4
Unresolved questions regarding cellular cysteine sources and their possible relationships to ferroptosis.关于细胞半胱氨酸来源及其与铁死亡可能关系的未解决问题。
Adv Cancer Res. 2024;162:1-44. doi: 10.1016/bs.acr.2024.04.001. Epub 2024 May 3.
5
Genetic Targets and Applications of Iron Chelators for Neurodegeneration with Brain Iron Accumulation.脑铁沉积所致神经退行性疾病中铁螯合剂的遗传靶点及应用
ACS Bio Med Chem Au. 2024 Mar 11;4(3):119-130. doi: 10.1021/acsbiomedchemau.3c00066. eCollection 2024 Jun 19.
6
Melatonin: a ferroptosis inhibitor with potential therapeutic efficacy for the post-COVID-19 trajectory of accelerated brain aging and neurodegeneration.褪黑素:一种铁死亡抑制剂,对 COVID-19 后加速大脑衰老和神经退行性变的轨迹具有潜在的治疗效果。
Mol Neurodegener. 2024 Apr 19;19(1):36. doi: 10.1186/s13024-024-00728-6.
7
Understanding the mechanistic roles of environmental heavy metal stressors in regulating ferroptosis: adding new paradigms to the links with diseases.理解环境重金属应激源在调控铁死亡中的机制作用:为其与疾病的关联增添新范式。
Apoptosis. 2023 Apr;28(3-4):277-292. doi: 10.1007/s10495-022-01806-0. Epub 2023 Jan 7.
8
Ferroptosis: A mixed blessing for infectious diseases.铁死亡:传染病的祸福相依
Front Pharmacol. 2022 Sep 7;13:992734. doi: 10.3389/fphar.2022.992734. eCollection 2022.
9
Iron Dysregulation in Mitochondrial Dysfunction and Alzheimer's Disease.线粒体功能障碍与阿尔茨海默病中的铁调节异常
Antioxidants (Basel). 2022 Mar 31;11(4):692. doi: 10.3390/antiox11040692.
10
NRF2: KEAPing Tumors Protected.NRF2:保护肿瘤的 KEAP1。
Cancer Discov. 2022 Mar 1;12(3):625-643. doi: 10.1158/2159-8290.CD-21-0922.